RTW Biotech Opportunities Ltd

RTW:LSE

RTW Biotech Opportunities Ltd

Actions
  • Price (USD)2.08
  • Today's Change0.014 / 0.68%
  • Shares traded99.15k
  • 1 Year change+55.52%
  • Beta1.2067
Data delayed at least 20 minutes, as of Feb 20 2026 12:50 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments5.362.726.97
Total Receivables, Net325823
Total Inventory------
Prepaid expenses------
Other current assets, total------
Total current assets------
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments611368350
Note receivable - long term------
Other long term assets------
Total assets760446402
LIABILITIES
Accounts payable------
Accrued expenses0.852.290.87
Notes payable/short-term debt951.2012
Current portion long-term debt/capital leases------
Other current liabilities, total245.3331
Total current liabilities------
Total long term debt000
Total debt951.2012
Deferred income tax------
Minority interest------
Other liabilities, total7.808.398.93
Total liabilities1271754
SHAREHOLDERS EQUITY
Common stock------
Additional paid-in capital------
Retained earnings (accumulated deficit)------
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total633429348
Total equity633429348
Total liabilities & shareholders' equity760446402
Total common shares outstanding336211212
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.